WELCOME TO THE HOME OF BIOTECH alphacarepharmaceutical.com
Uncovering the Latest Findings
We are alphacarepharmaceutical.com, an interdisciplinary Biomedical Research Lab Headquarter based in Canada Ontario while our branch in San Francisco (USA), Long water Avenue Reading (UK). We investigate novel concepts that underlie the complexities of our field. Our research is supported by funding from the government and a number of foundations.
We work with specialist focus groups, quality product research from India, Brazil, Prague, Dominican Republic, fund clinical trials and invest in care initiatives that optimize treatment programmes to improve quality of life.
Research & Discoveries
How we use our research for our therapies
An IIR is an unsolicited request for funding and/or material support (e.g., drug product) from an external investigator to conduct an independent scientific investigation. An IIR is conceived, designed, initiated, conducted, analysed, and reported by a qualified Investigator who is not an employee, contractor, or agent of Alpha Care Pharmaceuticals Ltd. and has the scientific background and experience to conduct an independent scientific investigation. To see our therapeutic areas of interest, please visit our therapies section.
Cell Culture
April 12, 2025
Gene Sequencing
April 12, 2025
Gene Transcription Enhancers
April 12, 2025
ABOUT-ALPHACARE PHARMACEUTICAL
Outstanding Quality
We deliver whole cell pellets, cell lysates, custom monoclonal antibody and recombinant protein manufacturing services from development to commercialization. We employ traditional cell culture methods as well as automated, single-use, perfusion bioreactors.
We have been focused on providing the right solutions supporting research through commercialization. We serve the diagnostic, genomic, animal health, food safety, pre-clinical and therapeutic industries. To speak with our experts, Contact Us
Why AlphaCare Pharmaceutical?
-
Over 40 years of experience in cell culture services from cell banking to product purification
-
Scaleable monoclonal antibody and protein production – from benchtop research to commercial quantities
-
Unique, single-use, continuous processing, perfusion hollow fiber bioreactor technology
Quality Policy:
Our expertise:
Manufacturing bioreactors and providing contract manufacturing services.
Our core values:
Continuous Improvement, Collaboration, & Consistency
These values are embodied in our Quality Management System and culture.
Our commitment:
Dedicating the necessary resources to ensure our products and services meet or exceed regulatory, customer, and internal requirements.
– Robert Wood, Chief Director Executive Officer
Marcus Gavin, International Purchase Manager
.